Table 4. Associations between F. nucleatum level and clinicopathological characteristics in cervical cancer.
| Variables | F. nucleatum level | ||
| Low | High | P | |
| Age, years | 0.145 | ||
| >35 | 37(43.5) | 48(56.5) | |
| ≤35 | 8(29.6) | 19(70.4) | |
| FIGO stage | 0.241 | ||
| IIA/IIB | 13(48.1) | 14(51.9) | |
| IB1/IB2 | 32(38.1) | 52(61.9) | |
| Greatest tumor dimension, cm | 0.521 | ||
| >4 | 9(39.1) | 14(60.9) | |
| ≤4 | 36(41.4) | 51(58.6) | |
| Lymphovascular space invasion | 0.459 | ||
| Yes | 3(50.0) | 3(50.0) | |
| No | 42(39.6) | 64(60.4) | |
| Depth of cervical invasion | 0.135 | ||
| ≥66% | 16(33.3) | 32(66.7) | |
| <66% | 15(48.4) | 16(51.6) | |
| Uterine corpus invasion | 0.065 | ||
| Yes | 19(32.2) | 40(67.8) | |
| No | 25(48.1) | 27(51.9) | |
| Pelvic lymph node metastasis | 0.327 | ||
| Yes | 10(45.5) | 12(54.5) | |
| No | 33(37.5) | 55(62.5) | |
| Differentiation b | 0.007 a | ||
| Poor | 21 (30.4) | 48(69.6) | |
| Well+moderate | 24(55.8) | 19(44.2) | |
| Recurrence | 0.015 a | ||
| Yes | 4(18.2) | 18(81.8) | |
| No | 41(45.6) | 49(54.4) | |
| Vital status(at follow-up) | 0.022 a | ||
| Death | 3 (16.7) | 15(83.3) | |
| Alive | 42(44.7) | 52(55.3) | |
aχ2 test. Significant P-values (<0.05) are shown in bold font.